KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Liabilities and Shareholders Equity (2016 - 2025)

Clorox (CLX) has 17 years of Liabilities and Shareholders Equity data on record, last reported at $5.6 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 0.65% year-over-year to $5.6 billion; the TTM value through Dec 2025 reached $22.2 billion, up 96.1%, while the annual FY2025 figure was $5.6 billion, 3.3% down from the prior year.
  • Liabilities and Shareholders Equity reached $5.6 billion in Q4 2025 per CLX's latest filing, up from $5.5 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q1 2021 and bottomed at $5.5 billion in Q1 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $6.0 billion, with a median of $6.0 billion recorded in 2023.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 10.1% in 2021, down 9.7% in 2021.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.2 billion in 2021, then fell by 2.34% to $6.0 billion in 2022, then fell by 2.27% to $5.9 billion in 2023, then decreased by 5.6% to $5.6 billion in 2024, then rose by 0.65% to $5.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $5.6 billion in Q4 2025, $5.5 billion in Q3 2025, and $5.6 billion in Q2 2025.